Company intelligence / Profile preview
The Ibn Sina Pharmaceutical Industry
Dhaka, Dhaka, Bangladeshibnsinapharma.com ↗
- Ownership
- Private
- Employees
- ~5200
- Development stage
- Other
01
Overview
The Ibn Sina Pharmaceutical Industry is a leading pharmaceutical manufacturer in Bangladesh with a diversified portfolio of over 600 products, including 475 pharmaceutical and 135 natural medicines. The company operates state-of-the-art cGMP-compliant facilities and exports to 17 countries, including the USA. It has a significant presence in the generic market and is expanding into biotech and sterile injectables.
- Therapeutic areas
- HematologyImmunologyEndocrinologyCardiovascularInfectious DiseasesPulmonologyGastroenterologyMetabolic Disorders
- Modalities
- Small moleculeNatural product
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
03
Partnerships
Directorate General of Drug Administration (DGDA)Fette CompactingSejong PharmatechRomaco GroupIMA Group
Beyond the preview
Go deeper on The Ibn Sina Pharmaceutical Industry.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on The Ibn Sina Pharmaceutical Industry.